Use of il-19, il-22 and il-24 to treat hematopoietic disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/20 (2006.01) A61K 38/19 (2006.01) A61K 39/395 (2006.01) A61P 7/00 (2006.01)

Patent

CA 2466229

The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders.

L'invention concerne un procédé relatif à l'utilisation d'une séquence de gènes mammaliens et de polypeptides codés par cette séquence pour le traitement de troubles hématopoïétiques chez des mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of il-19, il-22 and il-24 to treat hematopoietic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of il-19, il-22 and il-24 to treat hematopoietic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of il-19, il-22 and il-24 to treat hematopoietic disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2038350

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.